There are conflicting reports on the effect of Cannabis on brain cells, some reports support damage to brain cells while others do not. This work was carried out at the neuroscience unit of the Department of Veterinary Anatomy, University of Ibadan Oyo State, Nigeria. It investigated the neurodegenerative effect of extract of Cannabis sativa plant on brain regions in newborn Wistar rats exposed to Cannabis in utero and also combining the antioxidant and cell proliferative properties of folic acid to reverse these changes particularly in the Purkinje layer of the cerebellum in the group that received folic acid and cannabis. Four groups of pregnant Wistar rats were treated from Day 5 to 20 of pregnancy as follows: group A received 2ml of normal saline solution per os, group B received 2.0 mg /kg body weight of ethanolic extract of Cannabis sativa plant dissolved in normal saline per os, group C received 2.0 mg /kg body weight of Cannabis sativa extract and 40 mg/kg body weight of folic acid tablets (Emzor®) and group D received 2 mg/kg body weight of folic acid per os. The rat pups from group B showed deficit in locomotor function with spongiosis and astrogliosis in the corpus callosum, cerebellum and hippocampal regions of the brain. While pups from group A showed normal locomotor activities with no visible lesions in regions of the brain such as the cerebrum, cerebellum and the hippocampus. Group C pups were presented with normal locomotor activities with congestion of vessels in cerebrum and meninges and scattered areas of cell loss in the cerebrum, cerebellum hippocampus and corpus callosum and group D pups showed normal locomotor function, with vascular congestion in the meninges and cerebrum. We, therefore, concluded that folic acid which is a crucial factor in cell division, neurotransmitter production and an antioxidant in the nervous system could have a reversal of behavioural and locomotor deficits on nervous tissues exposed to Cannabis sativa extract by reducing the rate of cell death and increasing cellular stability and integrity in brain.
References
[1]
ElSohly, A.M. (2007) Marijuana and the Cannabinoids. Springer Science & Business Media, Berlin, 8. https://doi.org/10.1007/978-1-59259-947-9
http://books.google.com/books?id=fxoJPVNKYUgC&pg=PA8#v=onepage&q&f=false
Johnston, L.D., O’Malley, P.M. and Bachan, J.G. (2003) Monitoring the Future National Survey Results on Drug Use, 1975-2002: Vol. 1. Secondary School Students. NIH Pub. No. 03-5375. National Institute of Drug Abuse, Bethesda.
[4]
Compton, D.R., Aceto, M.D., Lowe, J. and Martin, B.R. (1996) In Vivo Characterization of a Specific Cannabinoid Receptor Antagonist (SR141716A): Inhibition of Delta 9-Tetrahydocannabinol-Induced Responses and Apparent Agonist Activity. Journal of Pharmacology and Experimental Therapeutics, 277, 586-594.
[5]
Mahlberg, P.L.G. and Kim, E.S. (2001) THC (Tetrahydrocannabinol) Accumulation in Glands of Cannabis (Cannabaceae). The Hemp Report 3 (17).
[6]
Sañudo-Peña, M.C., Romero, J., Seale, G.E., Fernandez-Ruiz, J.J. and Walker, J.M. (2000) Activational Role of Cannabinoids on Movement. European Journal of Pharmacology, 391, 269-274. https://doi.org/10.1016/S0014-2999(00)00044-3
[7]
Schultes, R.E., Klein, W.M., Plowman, T. and Lockwood, T.E. (1974) Cannabis: An Example of Taxonomic Neglect. Harvard University Botanical Museum Leaflets, 23, 337-367.
[8]
Cuomo, V., Mereu, G., Fà, M., Ferraro, L., Cagiano, R., Antonelli, T., Tattoli, M., Ghiglieri, V., Tanganelli, S. and Lluigi Gessa, G. (2003) Prenatal Exposure to a Cannabinoid Agonist Produces Memory Deficits Linked t o Dysfunction in Hippocampal Long-Term Potentiation and Glutamate Release. Proceedings of National Academy of Sciences of the United States of America, 100, 4915-4920.
https://doi.org/10.1073/pnas.0537849100
[9]
Adams, I.B., Ryan, W., Singer, M., Thomas, B.F., Compton, D.R., Razdan, R.K. and Martin, B.R. (1996) Evaluation of Cannabinoid Receptor Binding and in Vivo Activities for Anandamide Analogs. Journal of Pharmacology and Experimental Therapeutics, 273, 1172-1181.
[10]
Scallet, A.C., Uemura, E., Andrews, A., Ali, S.F., McMillan, D.E., Paule, M.G., Brown, R.M. and Sikker, W. (1987) Morphometric Studies of the Rat Hippocampus Following Chronic Delta-9-Tetrahydrocannabinol (THC). Brain Research, 436, 193-198. https://doi.org/10.1016/0006-8993(87)91576-9
[11]
Landfield, P.W., Cadwallader, L.B. and Vinsant, S. (1998) Quantitative Changes in Hippocampal Structure Following Long-Term Exposure to Delta 9-Tetrahydrocannabinol: Possible Mediation by Glucocorticoid Systems. Brain Research, 443, 47-62. https://doi.org/10.1016/0006-8993(88)91597-1
[12]
Chan, P.C., Sills, R.C., Bucher, J.R., Haseman, J.K. and Braun, A.G. (1996) Toxicity and Carcinogenicity of Delta 9 Tetrahydrocannabinol in Fischer Rats and B6C3F1 Mice. Journal of the Society of Toxicology, 30, 109-117.
[13]
Bailey, S.W. and Ayling, J.E. (2009) The Extremely Slow and Variable Activity of Dihydrofolate Reductase in Human Liver and Its Implication for High Folic Acid Intake. Proceedings of the National Academy of Sciences of the United States of America, 6, 15424-15429. https://doi.org/10.1073/pnas.0902072106
[14]
Weinstein, S.J., Terryl, J., Martman, R., Stalzenberg, S., Pirjo, P., Barret, M.J., Taylor, P.R., Virtamo, J. and Albanes, D. (2003) Null Association between Prostrate Cancer and Serum Folate, Vitamin B6, Vitamin B12 and Homocysteine. Cancer Epidemiology, Biomarkers, & Prevention, 12, 1271-1272.
http://cebp.aacrjournals.org/content/12/11/1271.full.pdf
[15]
Singh, R., Shalinder, S.K., Pooja, K.S. and Bimia, N. (2011) Beneficial Effects of Folic Acid on Enhancement of Memory and Anti-Oxidant Status in Aged Rat Brain. Cell Molecular Neurobiology, 31, 83-91. https://doi.org/10.1007/s10571-010-9557-1
[16]
Wang, J., Ge, J., Yang, L.N., Xue, D. and Li, J. (2011) Protective Effects and Its Mechanism on Neural Cells after Folic Acid Intervention in Preeclampsia Rat Model. Chinese Journal of Obstetrics and Gynecology, 46, 605-609.
[17]
Chan, G.C.K., Hinds, T.R., Impey, S. and Storm, D.R. (1998) Hippocampal Neurotoxicity of Delta 9-Tetrahydrocannabinol. Journal of Neuroscience, 18, 5322-5332.
https://doi.org/10.1523/JNEUROSCI.18-14-05322.1998
[18]
Kruman, Y., Culmsee, C., Chan, S.L., Guo, Z., Penix, L. and Mattson, M.P. (2000) Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity. The Journal of Neuroscience, 20, 6920-6926. https://doi.org/10.1523/JNEUROSCI.20-18-06920.2000
[19]
Adeniyi, P.A. and Musa, A.A. (2011) Comparative Effects of Smoke and Ethanoilic Extract of Nicotiana tabacum in Hippocampus and Neurobehavior of Mice. Research in Pharmacology and Biotechnology, 3, 68-74.
[20]
Todorich, B., Olopade, J.O., Surguladze, N., Zhang, X., Neely, E. and Connor, J.R. (2010) The Mechanism of Vanadium-Mediated Developmental Hypomyeli-Nation Is Related to Destruction of Oligodendrocyte Progenitors through a Relationship with Ferritin and Iron. Neurotoxicity Research, 19, 361-373.
https://doi.org/10.1007/s12640-010-9167-1
[21]
Garcia, G.B., Quiroga, A.D., Sturtz, N., Martinez, A.I. and Biancardi, M.E. (2004) Morphological Alterations of Central Nervous System (CNS) Myelin in Vanadium (V)-Exposed Adult Rats. Drug and Chemical Toxicology, 27, 281-293.
https://doi.org/10.1081/DCT-120037747
[22]
Soazo, M. and Garcia, G.B. (2007) Vanadium Exposure through Lactation Produces Behavioural Alterations and CNS Myelin Deficit in Neonatal Rats. Neurotoxicology and Teratology, 29, 503-510. https://doi.org/10.1016/j.ntt.2007.03.001
[23]
Galve-Roperh, I., Sanchez, C., Cortés, M.L., Gomez del, P.T., Izguierdo, M. and Guzman, M. (2000) Anti-Tumoral Action of Cannabinoids: Involvement of Sustained Ceramide Accumulation and Extracellular Signal-Regulated Kinase Activation. Nature Medicine, 6, 313-319. https://doi.org/10.1038/73171
[24]
Guzmán, M., Sánchez, C. and Galve-Roperh, I. (2001) Control of the Cell Survival/Death Decision by Cannabinoids. Journal of Molecular Medicine, 78, 613-625.
https://doi.org/10.1007/s001090000177
[25]
Craciunescu, C., Brown, E., Mar, M., Albright, C., Nadeau, M. and Zeisel, S.H. (2004) Folic Acid Deficiency during Late Gestation Decreases Progenitor Cell Proliferation and Increases Apoptosis in Fetal Mouse Brain. The Journal of Nutrition, 134, 162-166. https://doi.org/10.1093/jn/134.1.162
[26]
Chan, P., Sills, R.C., Braun, A.G., Haseman, J.K. and Bucher, J.R. (1996) Toxicity and Carcinogenicity of Δ9-Tetrahydrocannabinol in Fischer Rats and B6C3F1 Mice. Fundamental and Applied Toxicology, 30, 109-117.
https://doi.org/10.1006/faat.1996.0048
[27]
Adams, I.B. and Martin, B.R. (1996) Cannabis: Pharmacology and Toxicology in Animals and Humans. Addiction, 91, 1585-1514.
https://doi.org/10.1046/j.1360-0443.1996.911115852.x
[28]
Rodríguez de Fonseca, F., Del Arco, I.M., Calderón, J.L., Gorriti, M.A. and Navarro, M. (1998) Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity. Neurobiology of Disease, 5, 483-501.
https://doi.org/10.1006/nbdi.1998.0217
[29]
Solowij, N. (1998) Cannabis and Cognitive Functioning. Cambridge University Press, Cambridge. https://doi.org/10.1017/CBO9780511526824
[30]
Downer, E., Boland, B., Fogarty, M. and Campbell, V.A. (2001) Delta 9-Tetrahydrocannabinol Induces the Apoptotic Pathway in Cultured Cortical Neurones via Activation of the CB1 Receptor. NeuroReport, 12, 3973-3978.
https://doi.org/10.1097/00001756-200112210-00024
[31]
Peckny, M., Johansson, C.B., Eliasson, C., Stakeberg, J., Wallen, A., Perlmann, T. and Frisen, J. (1999) Abnormal Reaction to Central Nervous System Injury in Mice Lacking Fibrillary Acidic Protein and Vimentin. Journal of Cell Biology, 145, 503-514. https://doi.org/10.1083/jcb.145.3.503
